The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone in docetaxel-pretreated men with metastatic castration resistant prostate cancer (mCRPC): The CABACARE trial.
 
Carlo Buonerba
Honoraria - Sanofi/Aventis; Sanofi/Aventis
Consulting or Advisory Role - Sanofi/Aventis
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Quercegen Pharmaceuticals (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca/MedImmune; Sanofi/Aventis
 
Francesco Grillone
No Relationships to Disclose
 
Sabrina Rossetti
No Relationships to Disclose
 
Lorenzo Livi
No Relationships to Disclose
 
Mario Scartozzi
No Relationships to Disclose
 
Pierosandro Tagliaferri
No Relationships to Disclose
 
Dario Bruzzese
No Relationships to Disclose
 
Luca Scafuri
No Relationships to Disclose
 
Vittorio Riccio
No Relationships to Disclose
 
Ferdinando Costabile
No Relationships to Disclose
 
Davide Bosso
No Relationships to Disclose
 
Simona Iaccarino
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Simone Carrano
No Relationships to Disclose
 
Michela Izzo
No Relationships to Disclose
 
Michele Caraglia
No Relationships to Disclose
 
Sabino De Placido
No Relationships to Disclose
 
Giuseppe di Lorenzo
Speakers' Bureau - Sanofi/Aventis
Research Funding - Sanofi/Aventis (Inst)